CD36 and breast carcinoma: [28] conducted experiments where they spiked varying cell numbers (10, 100, 1000, and/or 10 000 cells) of the MDA‐MB‐231 breast cancer cell line to assess the isolation efficacy of DynaBeads®, EasySepTM, RosetteSepTM (containing anti‐CD36 system), and ScreenCell®.